MedTrace Logo

Reduction in Symptoms After Laser Therapy With Acorn aHFS

NCT06336135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2025-12-12

No results posted yet for this study

Summary

This study evaluates the severity and duration of symptoms experienced after laser therapy comparing four post-procedure topical products. Each product is applied to an individual region of interest (5 cm diameter) on the back or décolleté according to randomization code after laser therapy. The subject, blind to the product applied to each of 4 regions of interest, assesses eight symptoms daily for 14 days. Photography is performed daily.

Conditions

  • Skin Aging

Interventions

OTHER

autologous hair follicle derived secretome

aHFS is a cosmetic topical intended to be applied to the human body after skin resurfacing cosmetic procedures. aHFS is produced from the plucked hair follicles of each individual, making it autologous.

Sponsors & Collaborators

  • Acorn Biolabs Inc.

    lead INDUSTRY

Principal Investigators

  • Lisa Campbell, PhD · Acorn Biolabs Inc.

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-25
Primary Completion
2025-12-02
Completion
2025-12-02

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06336135 on ClinicalTrials.gov